Skip to main content

Type 2 Diabetes News

Type 2 Diabetes is a chronic condition involving high blood sugar levels and reduced production and responsiveness to insulin.     

Accu-Chek Connect System to be released on August 7 for $29.99.
US launch expected in 2017. 80% of trial participants still using it!
His daily routines, goals, and biggest advice for anyone trying to lose weight.
Leading ophthalmologist Dr. Ivan Suñer on what diabetic retinopathy is, how to prevent it, and what future treatments hold.
How do the trends compare to childhood type 2 diabetes?
Today, Lilly/BI announced first-ever news in diabetes: a major clinical trial on Jardiance , an SGLT-2 inhibitor pill for type 2 diabetes, has been proven to improve...
How 14 minutes of exercise can be one small step towards a healthier life.
What did four diabetes experts say was the most promising future innovation in diabetes?
Increased focus on sleep, mental health, and behavior – what other changes were made?
Plus, an interview with Dr. Anne Peters on 23andMe and the future of individualized care.
Enrollment period now open until January 31 – our guide to navigating the complex world of health insurance.
Turning clinical knowledge into real world examples, available for pre-order now!
Major 55% reduction in hypoglycemia (30 minutes less per day!); why didn’t A1c improve?
Leaders in diabetes weigh in at The diaTribe Foundation’s second-annual event in Europe.
Why I’m so moved by this $45 billion commitment and its focus on health equality.
Five patients share their experiences with the FDA-cleared, no-prescription-needed device. What did they like and how can it be made even better?
While Dexcom shook up the diabetes world when it announced a notable partnership with Google , the company also shared several other very exciting future product updates...
What can you learn about your health, your ancestry, and more?
Paving the way to healthier food options and preventing heart disease.
Smartphone user interface with no screen or buttons on the pump! Launch: 2018?

Pages